牛牛AI助理已提取核心讯息泰格医药2025年上半年实现营业收入32.50亿元人民币，同比下降3.2%；归属于上市公司股东的净利润3.83亿元，同比下降22.2%；毛利率为30.1%，同比下降9.6个百分点。其中，临床试验技术服务收入14.70亿元，同比下降10.2%；临床试验相关及实验室服务收入17.81亿元，同比增长3.5%。董事会决议不派发中期股息。从地域来看，中国内地业务收入16.98亿元，...
Source Link牛牛AI助理已提取核心讯息泰格医药2025年上半年实现营业收入32.50亿元人民币，同比下降3.2%；归属于上市公司股东的净利润3.83亿元，同比下降22.2%；毛利率为30.1%，同比下降9.6个百分点。其中，临床试验技术服务收入14.70亿元，同比下降10.2%；临床试验相关及实验室服务收入17.81亿元，同比增长3.5%。董事会决议不派发中期股息。从地域来看，中国内地业务收入16.98亿元，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.